ACT-293987 (NS-304)

· Actelion

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT-293987 (NS-304), covering 2025-09-12 to 2025-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of ACT-293987 (NS-304) in Pulmonary Arterial Hypertension (PAH) [Phase 2]